Infectious diseases: Advancing clinical research

The global burden of infectious diseases necessitates rapid, precise, and comprehensive molecular insights for effective clinical research, diagnostics, and therapeutic development. At OHMX.bio, we are at the forefront of applying advanced omics technologies to unravel the complexities of host-pathogen interactions, identify novel biomarkers, and support the development of next-generation interventions. Our expertise empowers researchers and clinicians with the high-resolution data needed to combat infectious threats.

Precision omics for infectious disease research

Understanding infectious diseases requires a multi-faceted approach, delving into pathogen genomics, host response, and the intricate dynamics of the microbiome. OHMX.bio offers a comprehensive suite of services tailored to meet these critical needs in clinical research:

Pathogen Genomics & Characterization

We provide robust whole-genome sequencing (WGS) and targeted sequencing solutions for precise identification, typing, and characterization of bacteria, viruses, fungi, and other pathogens. Our long-read sequencing capabilities are particularly advantageous for resolving complex genomic regions, structural variants, and tracking outbreak dynamics.

Host-Pathogen Interaction Analysis

Utilizing advanced RNA sequencing (RNA-seq), we enable in-depth analysis of gene expression patterns in host cells during infection. This allows for the identification of key pathways involved in immune response, disease progression, and therapeutic efficacy, providing crucial insights into the molecular mechanisms of infection.

Microbiome Analysis

The microbiome plays a significant role in health and disease, including susceptibility to and outcomes of infectious diseases. OHMX.bio offers comprehensive microbiome analysis services, including full-length 16S rRNA gene sequencing and metagenomics, to characterize microbial communities, identify dysbiosis, and explore their impact on infection.

Biomarker Discovery & Validation

Our expertise extends to the discovery and validation of novel biomarkers for infectious diseases. Leveraging NGS-based approaches, we can identify genetic, transcriptomic, and epigenetic markers that serve as indicators of infection, disease severity, treatment response, and patient stratification. Our capabilities support the translation of these biomarkers from discovery to clinical application.

OHMX.bio - Innovative omics solutions

Partner with OHMX.bio for your Infectious disease clinical research

OHMX.bio is dedicated to supporting your infectious disease clinical research with cutting-edge omics technologies and expert bioinformatics. Our commitment to scientific excellence, precision, and rapid turnaround times ensures that you receive the highest quality data and actionable insights.

Collaborate with OHMX.bio to accelerate your understanding of infectious diseases, develop more effective diagnostics, and advance novel therapeutic strategies.
OHMX.bio_Innovative omics solutions_Tailored Personal Approach

Let’s get in touch!

Are you curious about how we can work on your -omics challenges together? Fill out the form below!
Our experts will reply within 2 working days to freely discuss your omics project.

Our publications using our cell en gene therapies

  1.